A prognostic nomogram based on a new classification of combined micropapillary and solid components for stage IA invasive lung adenocarcinoma

Author(s):  
Wuhao Huang ◽  
Hua Zhang ◽  
Zhiwei Zhang ◽  
Bin Zhang ◽  
Xiaoyan Sun ◽  
...  
2017 ◽  
Vol 12 (1) ◽  
pp. S649
Author(s):  
Masaoki Ito ◽  
Yoshihiro Miyata ◽  
Kei Kushitani ◽  
Tomoharu Yoshiya ◽  
Yasuhiro Tsutani ◽  
...  

Lung Cancer ◽  
2015 ◽  
Vol 90 (2) ◽  
pp. 199-204 ◽  
Author(s):  
Shuji Murakami ◽  
Hiroyuki Ito ◽  
Norifumi Tsubokawa ◽  
Takahiro Mimae ◽  
Shinsuke Sasada ◽  
...  

2012 ◽  
Vol 136 (10) ◽  
pp. 1190-1193 ◽  
Author(s):  
Keith M. Kerr

Clinical need and developments in pathology and molecular biology require our cancer classifications to be constantly updated to keep them relevant and useful. A review of lung cancer classification is due and has been initiated with new proposals on classification of lung adenocarcinoma. Other major lung cancer types also deserve a similar consideration. As well as addressing the categories of tumor, as signed out in surgical resection specimens, recent proposals on small diagnostic-sample reporting would be an important addition to any new classification. The huge increase in data on the molecular biology of lung cancer has improved our understanding of these diseases, has driven improved therapy for some patients, and must be reflected in the way lung cancer is classified.


2020 ◽  
Author(s):  
Wenshu Chen ◽  
Yun Ding ◽  
Peilin You ◽  
Pengjie Tu ◽  
Jianyuan Huang ◽  
...  

Abstract Background Lung cancer is one of the most common malignant tumors with poor prognosis. Even for stage IA, many cases relapsed after completed resection. In the era of precision medicine, it is of great significance to determine the risk factors for postoperative recurrence or death in stage IA invasive lung adenocarcinoma. Methods The data of patients with pathological stage IA invasive lung adenocarcinoma underwent complete resection from June 2012 to December 2016 in Fujian Provincial Hospital were collected and retrospectively analyzed. Recurrence-free survival (RFS) was estimated by the Kaplan-Meier method and compared with the log-rank test. The Cox proportional risk model was used to analyze the factors affecting the RFS. Results A total of 210 patients were enrolled in the study. During the follow-up period, 14 (6.7%) patients recurred. Univariate survival analysis showed that predominant pathological subtype, micropapillary/solid pattern, stage T1b and lymphovascular invasion were correlated with RFS (P < 0.05). Cox multivariate analysis showed that the micropapillary/solid pattern was associated with RFS (P < 0.01). Patients with micropapillary/solid pattern had a worse 5-year RFS rate than those without micropapillary/solid pattern (82.3% versus 96.7%, P < 0.001). Conclusion Pathological subtype is a prognostic factor for patients with pathological stage IA invasive lung adenocarcinoma. Patients with micropapillary/solid pattern have a poor prognosis. Lymphovascular invasion and stage T1b are also correlated with poor RFS. These findings may serve as reliable predictive factors for long-term prognostic, and provide theory evidence for the choice of postoperative adjuvant therapy for patients with lung adenocarcinoma in stage IA.


1971 ◽  
Vol 12 (7) ◽  
pp. 262-266
Author(s):  
K. F. Chudoba
Keyword(s):  

2020 ◽  
pp. 66-74
Author(s):  
E. Zakablukovskiy

The article highlights certain aspects of the discussion on the topic of reductionism vs. holism in the philosophy of medicine. Classic radical reductionism is defeated by the concept of emergence. The s.c. bio-medical point of view on a malady, despite its relevance and clear benefit, is not recognized as universal as its adherents may claim, and it yields to an integral psycho-bio-social model. The author introduces a new classification of holism (vitalistic, social and individualistic) and makes appropriate recommendations to clinicians. It is social holism at the macro level that has proven effective in combating the spread of COVID-19.


Sign in / Sign up

Export Citation Format

Share Document